EligibleTrials

Camrelizumab (SHR-1210), Pemetrexed, and Carboplatin: clinical trials recruiting now

Fewer than 3 recruiting trials found.

1
Recruiting trials
2
Conditions studied
0
US states with sites
1
Countries

Phase breakdown

Phase 2 1

Conditions being studied

ConditionTrials
Lung cancer1
Non Squamous Non Small Cell Lung Cancer1

Recruiting trials involving Camrelizumab (SHR-1210), Pemetrexed, and Carboplatin

Common questions

How many recruiting trials involve Camrelizumab (SHR-1210), Pemetrexed, and Carboplatin?

1 recruiting trial across 2 conditions.

Is this list of trials complete?

No. For the full record, search ClinicalTrials.gov.

Get notified when new trials open

One email when new recruiting trials are added. Unsubscribe anytime.